Cargando…

Novel reaction to new cystic fibrosis medication Trikafta

We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stashower, Julian, Carr, Patrick, Miller, Virginia, Zlotoff, Barrett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122137/ https://www.ncbi.nlm.nih.gov/pubmed/34026156 http://dx.doi.org/10.1002/ccr3.4116

Ejemplares similares

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis
por: Lepissier, Agathe, et al.
Publicado: (2023)

THE IMPACT OF TRIKAFTA (ELEXACAFTOR/IVACAFTOR/TEZACAFTOR) ON PATIENTS WITH CYSTIC FIBROSIS WITH COVID-19
por: MILES, B., et al.
Publicado: (2022)

A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
por: Zaher, Anas, et al.
Publicado: (2021)

Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta
por: Liessi, Nara, et al.
Publicado: (2020)

The cystic fibrosis treatment Trikafta affects the growth, viability, and cell wall of Aspergillus fumigatus biofilms
por: Jones, Jane T., et al.
Publicado: (2023)

Trikafta—Extending Its Success to Less Common Mutations
por: Bentur, Lea, et al.
Publicado: (2022)

Molecular Structures Reveal Synergistic Rescue of Δ508 CFTR by Trikafta Modulators
por: Fiedorczuk, Karol, et al.
Publicado: (2022)

Phenotyping Rare CFTR Mutations Reveal Functional Expression Defects Restored by TRIKAFTA(TM)
por: Laselva, Onofrio, et al.
Publicado: (2021)

Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study
por: Gur, Michal, et al.
Publicado: (2022)

Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Child with Cystic Fibrosis
por: Abushahin, Ahmed, et al.
Publicado: (2023)

Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
por: Veit, Guido, et al.
Publicado: (2020)

How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old
por: Prados, C., et al.
Publicado: (2017)

Ralstonia mannitolilytica in cystic fibrosis: A new predictor of worse outcomes
por: Coman, I., et al.
Publicado: (2016)

The Novel CFTR Mutation A457P in a Male with a Delayed Diagnosis of Cystic Fibrosis
por: Cole, Kate H., et al.
Publicado: (2011)

Atypical Presentation of Cystic Fibrosis in An Infant
por: Sahoo, Bandya, et al.
Publicado: (2022)

Novel CFTR Mutations in a Korean Infant with Cystic Fibrosis and Pancreatic Insufficiency
por: Choe, Young June, et al.
Publicado: (2010)

Identification of a Novel Mutation of CFTR Gene in a Korean Patient with Cystic Fibrosis
por: Ko, Jung Min, et al.
Publicado: (2008)

A new future for patients with cystic fibrosis
por: Pullen, Lara C.
Publicado: (2020)

Posaconazole‐induced hypertension in children with cystic fibrosis
por: Marpole, Rachael, et al.
Publicado: (2021)

Pulmonary Nocardiosis in an Immunocompetent Patient with Cystic Fibrosis
por: Schoen, Lucy, et al.
Publicado: (2015)

Pancreatic Cystosis in Two Adolescents with Cystic Fibrosis
por: Hatziagorou, Elpis, et al.
Publicado: (2016)

Pulmonary Tuberculosis in a Patient with Cystic Fibrosis
por: Patil, Naveen, et al.
Publicado: (2015)

Burkholderia pseudomallei in cystic fibrosis and treatment complications
por: Radhakrishna, Naghmeh, et al.
Publicado: (2015)

Acute retinal vein occlusion and cystic fibrosis
por: Starr, Matthew R., et al.
Publicado: (2018)

Bordetella bronchiseptica in non-cystic fibrosis bronchiectasis
por: Karamooz, Elham, et al.
Publicado: (2018)

Pseudomonas pharyngitis in a cystic fibrosis patient
por: Pradeepan, Shyamala, et al.
Publicado: (2018)

Progressive Scoliosis in a Child with Cystic Fibrosis
por: Castner, Lauren M., et al.
Publicado: (2019)

Pseudo‐Bartter syndrome in children with cystic fibrosis
por: Faraji‐Goodarzi, Mojgan
Publicado: (2019)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Cystic fibrosis and COVID-19: Care considerations
por: Mirza, Alicia A., et al.
Publicado: (2020)

COVID-19 in a Cystic Fibrosis Patient
por: Al Lawati, Adil, et al.
Publicado: (2023)

Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
por: Kerkhoff, Andrew D., et al.
Publicado: (2017)

Gender-affirming hormone therapy in cystic fibrosis – A case of new Pseudomonas infection
por: Shaffer, L., et al.
Publicado: (2021)

Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report
por: Levy, Hara, et al.
Publicado: (2010)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Case report of compound CFTR variants in Korean siblings with cystic fibrosis: importance of differentiating cystic fibrosis from inflammatory bowel disease
por: Park, Hyejin, et al.
Publicado: (2021)

Reporting Two Novel Mutations in Two Iranian Families with Cystic Fibrosis, Molecular and Bioinformatic Analysis
por: Hosseini Nami, Amin, et al.
Publicado: (2022)

“Reactance inversion” at low frequencies in a child undergoing treatment of a cystic fibrosis exacerbation
por: Allen, Julian Lewis, et al.
Publicado: (2019)

Elevated sweat chloride test: is it always cystic fibrosis?
por: Cimbalo, C., et al.
Publicado: (2021)

Acute Appendicitis Masquerading Distal Intestinal Obstruction Syndrome in Adult Cystic Fibrosis
por: Nanavati, Sushant M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ib783cfq5hrmf90maelqjlhps